Evidence map›Paper›PMID 41492017›Full record

GuidelineClinical rheumatology2026

PAFLAR guidelines for oligoarticular juvenile idiopathic arthritis.

Waleed Hassan, Doaa Mosad Mosa, Ayodele Faleye, Temesgen Teferi Libe, Elisa Palalane, Angela Migowa, Sulaiman Al Mayouf, Helen Foster, Mohammed Hassan Abu-Zaid, Soad Hashad and 17 more

Abstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Waleed HassanRheumatology and Rehabilitation Department, Benha University, Banha, Egypt.ORCID http://orcid.org/0000-0002-3238-6804
Doaa Mosad MosaDepartment of Rheumatology & Rehabilitation, Mansoura University Hospitals, Faculty of Medicine, Mansoura University, Mansoura, Egypt. doaamosad@mans.edu.eg.ORCID http://orcid.org/0000-0002-1220-7215
Ayodele FaleyePediatric Rheumatology Unit, Department of Pediatrics, Teaching Hospital, Lagos State University, Lagos, Nigeria.
Temesgen Teferi LibeCollege of Health and Medical Sciences, Haramaya University, Dire Dawa, Ethiopia.ORCID http://orcid.org/0000-0003-4452-5573
Elisa PalalaneHospital Central de Maputo, Maputo, Mozambique.
Angela MigowaDepartment of Paediatrics and Child Health, Aga Khan University Hospital, Nairobi, Kenya.ORCID http://orcid.org/0000-0002-1146-7963
Sulaiman Al MayoufKing Faisal Specialist Hospital and Research Center College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0003-0142-6698
Helen FosterPopulation Health and Society Institute, Newcastle University, Newcastle Upon Tyne, UK.ORCID http://orcid.org/0000-0001-8824-2546
Mohammed Hassan Abu-ZaidRheumatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.ORCID http://orcid.org/0000-0001-8436-8598
Soad HashadUniversity of Tripoli, Tripoli, Libya.
Wafa HamdiDepartment of Rheumatology, Kassab Institute UR17SP04, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.ORCID http://orcid.org/0000-0003-3045-4831
Hanene Lassoued FerjaniDepartment of Rheumatology, Kassab Institute UR17SP04, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.ORCID http://orcid.org/0000-0002-8658-0936
Ahmed SeriEuropean Academy of Allergy and Clinical Immunology, Zurich, Switzerland.
Hanna LishanAddis Ababa University, College of Health Sciences, Addis Ababa, Ethiopia.
Chafia Makhloufi DahouDepartment of Rheumatology, Faculty of Medicine of Algiers, Med Lamine Debaghine University Hospital, Bab El Oued, BD Said Touati, Algiers, Algeria.ORCID http://orcid.org/0000-0002-6523-9851
Yasmine MakhloufMohammed Kassab Institute of Orthopaedics, Tunis, Tunisia.
Yasmine TahaAhmed Gasim Children's Hospital, Khartoum North, Sudan.
Yaninga Halwani FusseiniTamale Teaching Hospital, Tamale, Ghana.
Wassila MessadiUniversity Hospital of Issaad Hassani, Algiers, Algeria.
Ali SobhMansoura University Children's Hospital, Mansoura, Egypt.ORCID http://orcid.org/0000-0001-7047-076X
Samah Ismail NasefSuez Canal University, Ismailia, Egypt.ORCID http://orcid.org/0000-0002-8875-2455
Ourida GacemSociete Algerienne de Pediatrie, Blida, Algeria.ORCID http://orcid.org/0000-0002-9690-0569
Madeleine NgandeuUniversity of Yaounde, Soa, Cameroon.
Francis Fredrick FuriaDepartment of Paediatrics and Child Health, School of Clinical Medicine, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.ORCID http://orcid.org/0000-0003-2668-3041
Samy Slimani, Batna, Algeria.ORCID http://orcid.org/0000-0001-9332-3551
Christiaan ScottUniversity of Ottawa, Ottawa, Canada.
Djohra HadefFaculty of Medicine, Batna 2 University, Batna, Algeria.ORCID http://orcid.org/0000-0002-1949-4966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo present updated evidence-based recommendations with a range of therapeutic options for children in Africa with oligoarticular juvenile idiopathic arthritis (JIA), adopting the treat to-target approach.

methodsThis study was conducted by the Paediatric Society of the African League Against Rheumatism (PAFLAR) to reach a consensus for recommendations regarding diagnosis and management of oligoarticular JIA suitable for application among different African countries. The Delphi technique was used to reach a consensus of 15 key questions identified by the steering committee. According to the PICO (patient/population, intervention, comparison, outcome) approach, a voting process among 22 African and international clinicians and experts in the field of pediatric rheumatology was performed after intensive systematic review of literature.

resultsA consensus was reached for 15 recommendations for diagnosis, monitoring, management of the disease, and its complications, intervention, and when to discontinue treatment of oligoarticular JIA patients with high level of agreement (ranging between 85 and 95%) who agreed or strongly agreed, and the response rate was 100%.

conclusionThese recommendations focus on the early diagnosis and multidisciplinary management of oligoarticular JIA and its complications with high levels of consensus and agreement, improving practice consistency among healthcare providers. Key Points • A panel of experts created a consensus about the early diagnosis of oligoarticular JIA • Consensus-based recommendations to the management of oligoarticular JIA • These guidelines emphasized on the oligoarticular JIA-specific characteristics, severity factors, and treatment alternatives.

Indexed as

Antirheumatic AgentsArthritis, JuvenileAfricaChildConsensusDelphi TechniqueHumansRheumatologyAntirheumatic AgentsArthritisGuidelinesJuvenileOligoarticularTreatment

Identifiers

PMID41492017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.